 |
|
|
|
John Alam was previously the Senior Vice President of Drug Evaluation and Approval at
Vertex Pharmaceuticals.
Dr. Alam joined Vertex in October 1997 from
Biogen, Inc.,
where he
held a variety of positions from 1991-1997, including Director of
Medical Research and Program Executive for Avonex (beta
interferon). Prior to joining Biogen, Dr. Alam was a Research Fellow
at the Dana Farber Cancer Institute and had completed an internal
medicine residency at Brigham and Women's Hospital in Boston.
Dr. Alam holds an MD from Northwestern University Medical School and a
S.B. in Chemical Engineering from the Massachusetts Institute of
Technology.
|
|
|
|
Board of Directors 